Search

Your search keyword '"W. Löffler"' showing total 484 results

Search Constraints

Start Over You searched for: Author "W. Löffler" Remove constraint Author: "W. Löffler"
484 results on '"W. Löffler"'

Search Results

1. Purification of a single-photon nonlinearity

2. A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2

3. Identification and relative abundance of naturally presented and cross-reactive influenza A virus MHC class I-restricted T cell epitopes

4. Peptide-stimulated T cells bypass immune checkpoint inhibitor resistance and eliminate autologous microsatellite instable colorectal cancer cells

5. First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster

6. Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency

7. T cells of colorectal cancer patients’ stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells

8. A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

9. Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma

11. A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer

12. Platelets Aggregate With Neutrophils and Promote Skin Pathology in Psoriasis

13. Einfluss der Coronapandemie auf die Leberchirurgie und Lebertransplantationen in Deutschland

14. Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups

16. Supplementary Table 6 from Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation

17. Supplementary Table 8 from Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation

18. Supplementary Tables 1-5, 7, 9-12 from Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation

19. Data from Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation

20. Data from Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma

21. Supplementary Data from Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma

22. Supplementary Figures 1-6 from Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation

23. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

24. NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials

25. SARS-CoV-2-Infektionen und klinische Konsequenzen bei organtransplantierten Patienten im Rahmen der ersten Ansteckungswelle in Deutschland - eine monozentrische Umfrage und ein Fallbericht

26. T cells of colorectal cancer patients' stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells

27. Establishment of a novel method to assess MEK1/2 inhibition in PBMCs for clinical drug development

28. A Prospective, Phase I/II, Open-Label Pilot Trial to Assess the Safety of Hyperthermic Intraperitoneal Chemotherapy After Oncological Resection of Pancreatic Adenocarcinoma

29. [Impact of the SARS-CoV-2 Pandemic on Liver Surgery and Liver Transplantations in Germany]

30. [Current status of surgical treatment of peritoneal metastases from colorectal cancer]

31. Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study

32. Gaia Early Data Release 3 The Gaia Catalogue of Nearby Stars

33. Cytoreductive surgery and HIPEC in colorectal cancer—did we get hold of the wrong end of the stick?

34. Individualisierte Immuntherapie von Tumorerkrankungen mittels Peptidimpfstoffen – Funktioniert das vielleicht doch?

35. Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire

36. Tumorvakzinierung – therapeutische Vakzinierung gegen Krebs

37. Orf Virus-Based Vectors Preferentially Target Professional Antigen-Presenting Cells, Activate the STING Pathway and Induce Strong Antigen-Specific T Cell Responses

38. Quantum detector tomography applied to the human visual system: a feasibility study

39. A survey among physicians in surgery and anesthesiology departments after the first surge of SARS-CoV-2 infections in Germany : Preparing for further challenges ahead

40. Phase I/II multicenter trial of a novel therapeutic cancer vaccine, HepaVac-101, for hepatocellular carcinoma

41. Release of the Pre-Assembled naRNA-LL37 Composite DAMP Re-Defines Neutrophil Extracellular Traps (NETs) as Intentional DAMP Webs

42. Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study

44. Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model

45. Integrin activation enables rapid detection of functional Vδ1

46. Can Any Drug Be Repurposed for Cancer Treatment? A Systematic Assessment of the Scientific Literature

47. Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy

48. Elective cancer surgery in COVID-19–Free surgical pathways during the SARS-cov-2 pandemic: An international, multicenter, comparative cohort study

49. [SARS-CoV-2 Infections and Clinical Consequences in a Cohort of Solid Organ Transplant Recipients during the first Wave in Germany - a Single Centre Survey and a Case Report]

50. Revisited Upper Reference Limits for Highly Sensitive Cardiac Troponin T in Relation to Age, Sex, and Renal Function

Catalog

Books, media, physical & digital resources